Anastrozole Tablets Market: Introduction
- Anastrozole is an oral non-selective aromatase inhibitor approved for adjuvant treatment of early-stage, hormone receptor-positive breast cancer in postmenopausal women. It also reduces plasma estrogen levels by inhibiting aromatase. This drug also has some common side effects such as hot flashes, altered mood, joint pain, and nausea.
Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78775
Key Drivers and Restraints of Global Anastrozole Tablets Market
- Prevalence of postmenopausal breast cancer has increased globally. In 2018, the age-standardized incident rates per 100,000 was 19.7 cases of premenopausal and 152.6 cases of postmenopausal breast cancer. The highest premenopausal breast cancer age-standardized incident rates was in Western Europe (38.4 per 100,000). Breast cancer is the most frequent cancer among women, affecting 2.1 million women each year and causes the largest number of cancer-related deaths among women. In 2018, an estimated 627,000 women died of breast cancer i.e., nearly 15% of all cancer deaths among women. Hence, rise in cases of various diseases fuels market growth.
Request for Analysis of COVID19 Impact on Anastrozole Tablets Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78775
- Product launch is also boosting market revenue. In July 2024, Aurobindo Pharma Limited received the U.S. FDA approval for Anastrozole Tablets USP, 1 mg. In September 2019, Cooper Pharma launched ANAZBOL (anastrozole tablets) in New Delhi, India, to treat breast cancer in women who have gone through menopause.
- However, frequent product recalls is likely to restrain the global market. In July 2019, Cadila Healthcare recalled its Anastrozole tablets. This recall was issued due to GMP deviations and potential cross-contamination due to cleaning procedure failure. In April 2019, Zydus recalled anastrozole due to a GMP cleaning procedure failure in the Fluid Bed Dryer Processor area. This recall was initiated in support of the recall by the manufacturer, Zydus, dated May 3, 2019, which included lots that were repackaged by American Health Packaging.
Pre-Book Anastrozole Tablets Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=78775<ype=S
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers’ or customers’ journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
More Trending Reports by Transparency Market Research:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
